1. Home /
  2. Drug Approvals

Drug Approvals

Assessing AstraZeneca in the Fight Against the Virus

While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.

Here Are 2 'Stocking Stuffers' for Covered Call Aficionados

I added to my stake in UniQure and initiated a new position in Lexicon Pharmaceuticals.

Markets This Week, Cyber-Espionage, Stimulus at Hand, 'New' Covid Strain

Are traders working this holiday shortened week? You bet they are.

2 Hot Biotech Stocks That No Longer Are Bargains

Ocular Therapeutix and TG Therapeutics are still promising companies, but their recent runs higher make them pricey at this point.

Season of the Witch, Indices Run Wild, Enter Moderna, FedEx Delivers

Plus, Coinbase files for an eventual initial public offering that should draw a ton of interest.

Psychedelic Industry Setting Up For an Even Bigger 2021

Dealmaking is going strong and looks set to continue as mental health becomes a key investment theme going forward.

Biotech Veru's Treatment Could Be a Game Changer, but What About the Stock?

Let's check out the charts of this biotech name.

2 Potential Acquisition Targets as Biotech Deal Activity Picks Up

BioXcel Therapeutics and Avadel Pharmaceuticals would make good additions to the portfolios of larger drug companies.

A Glance Behind, Sifting Through Events to Come, Waiting for Santa

Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).

Jim Cramer: Bring on the Vaccine, I'm Ready

The sooner that we get jabbed the more likely the economy can spring back to life.